Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1869937-48-3
Created by
admin on Tue Apr 01 20:26:00 GMT 2025 , Edited by admin on Tue Apr 01 20:26:00 GMT 2025
|
PRIMARY | |||
|
100000175803
Created by
admin on Tue Apr 01 20:26:00 GMT 2025 , Edited by admin on Tue Apr 01 20:26:00 GMT 2025
|
PRIMARY | |||
|
C123828
Created by
admin on Tue Apr 01 20:26:00 GMT 2025 , Edited by admin on Tue Apr 01 20:26:00 GMT 2025
|
PRIMARY | |||
|
249EAP69MT
Created by
admin on Tue Apr 01 20:26:00 GMT 2025 , Edited by admin on Tue Apr 01 20:26:00 GMT 2025
|
PRIMARY | |||
|
DE-150
Created by
admin on Tue Apr 01 20:26:00 GMT 2025 , Edited by admin on Tue Apr 01 20:26:00 GMT 2025
|
PRIMARY | |||
|
Cofetuzumab pelidotin
Created by
admin on Tue Apr 01 20:26:00 GMT 2025 , Edited by admin on Tue Apr 01 20:26:00 GMT 2025
|
PRIMARY | |||
|
10674
Created by
admin on Tue Apr 01 20:26:00 GMT 2025 , Edited by admin on Tue Apr 01 20:26:00 GMT 2025
|
PRIMARY |
ACTIVE MOIETY